Literature DB >> 3106074

Modulation of arterial smooth muscle cells from contractile to synthetic phenotype requires induction of ornithine decarboxylase activity and polyamine synthesis.

J Thyberg, B B Fredholm.   

Abstract

The role of polyamines in modulating cultivated arterial smooth muscle cells from contractile to synthetic phenotype was studied by biochemical and electron microscopic methods. Ornithine decarboxylase (ODC), the first and overall rate-limiting enzyme in polyamine biosynthesis, showed no detectable activity in freshly isolated contractile cells, rose to a peak of activity after 2 days of culture, simultaneously with the most rapid phase of phenotypic modulation, and thereafter returned to a lower level of activity. The increase in ODC activity was accompanied by a gradual rise in the cellular concentrations of the polyamines putrescine, spermidine and spermine. The polyamine synthesis inhibitors alpha-difluoromethylornithine and methylglyoxal-bis(guanylhydrazone) prevented transition into synthetic phenotype as well as initiation of cell growth. The results indicate that polyamines play an important role in the control of smooth muscle phenotype and growth.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106074     DOI: 10.1016/0014-4827(87)90124-8

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  5 in total

1.  The modulation of smooth muscle cell phenotype is an early event in human aorto-coronary saphenous vein grafts.

Authors:  M M Kockx; B A Cambier; H E Bortier; G R De Meyer; P A Van Cauwelaert
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 2.  Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives.

Authors:  Harm Maarsingh; Johan Zaagsma; Herman Meurs
Journal:  Br J Pharmacol       Date:  2009-08-24       Impact factor: 8.739

Review 3.  Arginase and pulmonary diseases.

Authors:  Harm Maarsingh; Tonio Pera; Herman Meurs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-24       Impact factor: 3.000

4.  Arginase and arginine dysregulation in asthma.

Authors:  Renée C Benson; Karen A Hardy; Claudia R Morris
Journal:  J Allergy (Cairo)       Date:  2011-04-26

5.  Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells.

Authors:  L Li; J M Miano; B Mercer; E N Olson
Journal:  J Cell Biol       Date:  1996-03       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.